Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li Ding

Showing results (31-40 of 2,368) with videos related to

Pageof 237
Sort By:
Molecular Medicine Reports|August 25, 2022
[Retracted] microRNA‑188 acts as a tumour suppressor in glioma by directly targeting the IGF2BP2 geneLi Ding, Ling Wang, Feng Guo
Frontiers in Endocrinology|September 19, 2022
Editorial: Monogenic diabetes: from genetics and cell biology to clinical practiceLi Ding, Fabrizio Barbetti, Ming Liu
Frontiers in Cardiovascular Medicine|December 9, 2024
Surgical outcomes in adolescents and adults with anomalous aortic origin of a coronary arteryBaotong Li, Li Ding, Hansong Sun
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 3, 2024
RNA therapeutics targeting PD-L1 is a promising immune-activation strategy against difficult-to-treat cancersLi Ding, Bin Deng, Gang Chen
The Journal of Nervous and Mental Disease|October 19, 2020
Relationship and Effects of Community Problems on Anxiety and Suicide: A Case-Control Psychological Autopsy StudyJuncheng Lyu, Li Ding, Jie Zhang
Entropy (Basel, Switzerland)|December 3, 2020
Analytical Solutions for Multi-Time Scale Fractional Stochastic Differential Equations Driven by Fractional Brownian Motion and Their ApplicationsXiao-Li Ding, Juan J Nieto
Optics Express|July 21, 2015
In situ UV nano-imprint lithography alignment using high contrast markJin Qin, Li Ding, Liang Wang
Cell Cycle (Georgetown, Tex.)|August 3, 2022
Circ_0001955 promotes the progression of non-small cell lung cancer via miR-769-5p/EGFR axisLi Ding, Yinan Feng, Longguang Li
European Urology|November 24, 2023
Re: Fred Saad, Noel W. Clarke, Mototsugu Oya, et al. Olaparib plus Abiraterone Versus Placebo plus Abiraterone in Metastatic Castration-resistant Prostate Cancer (PROpel): Final Prespecified Overall Survival Results of a Randomised, Double-blind, Phase 3 Trial. Lancet Oncol 2023;24:1094-108Li Ding, Bin Yang, Xudong Yao
Pathology Oncology Research : POR|December 13, 2018
Approach the Invasive Potential with Hurthle Cell Tumors of ThyroidLi Ding, Yunhui Jiang, Wan Yang
Pageof 237

Showing results (31-40 of 2,368) with videos related to

Sort By:
Pageof 237
Molecular Medicine Reports|August 25, 2022
[Retracted] microRNA‑188 acts as a tumour suppressor in glioma by directly targeting the IGF2BP2 geneLi Ding, Ling Wang, Feng Guo
Frontiers in Endocrinology|September 19, 2022
Editorial: Monogenic diabetes: from genetics and cell biology to clinical practiceLi Ding, Fabrizio Barbetti, Ming Liu
Frontiers in Cardiovascular Medicine|December 9, 2024
Surgical outcomes in adolescents and adults with anomalous aortic origin of a coronary arteryBaotong Li, Li Ding, Hansong Sun
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 3, 2024
RNA therapeutics targeting PD-L1 is a promising immune-activation strategy against difficult-to-treat cancersLi Ding, Bin Deng, Gang Chen
The Journal of Nervous and Mental Disease|October 19, 2020
Relationship and Effects of Community Problems on Anxiety and Suicide: A Case-Control Psychological Autopsy StudyJuncheng Lyu, Li Ding, Jie Zhang
Entropy (Basel, Switzerland)|December 3, 2020
Analytical Solutions for Multi-Time Scale Fractional Stochastic Differential Equations Driven by Fractional Brownian Motion and Their ApplicationsXiao-Li Ding, Juan J Nieto
Optics Express|July 21, 2015
In situ UV nano-imprint lithography alignment using high contrast markJin Qin, Li Ding, Liang Wang
Cell Cycle (Georgetown, Tex.)|August 3, 2022
Circ_0001955 promotes the progression of non-small cell lung cancer via miR-769-5p/EGFR axisLi Ding, Yinan Feng, Longguang Li
European Urology|November 24, 2023
Re: Fred Saad, Noel W. Clarke, Mototsugu Oya, et al. Olaparib plus Abiraterone Versus Placebo plus Abiraterone in Metastatic Castration-resistant Prostate Cancer (PROpel): Final Prespecified Overall Survival Results of a Randomised, Double-blind, Phase 3 Trial. Lancet Oncol 2023;24:1094-108Li Ding, Bin Yang, Xudong Yao
Pathology Oncology Research : POR|December 13, 2018
Approach the Invasive Potential with Hurthle Cell Tumors of ThyroidLi Ding, Yunhui Jiang, Wan Yang
Pageof 237